Stocks / NASDAQ / Gain Therapeutics Inc.

Gain Therapeutics Inc.

Our Opinion

Gain Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“Dr. Beatriz Guzman, Gain’s in-vivo Research Pharmacologist, presented data of STAR compounds exhibiting positive in-vivo pharmacological activity in animal models of Parkinson’s Disease.” Read the following article

Company Description

Gain Therapeutics, Inc. is a holding company. The Company, through its subsidiary, GT Gain Therapeutics SA, is a development stage biotechnology company. The Company is focused on developing therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders (LSDs), including rare genetic diseases and neurological disorders.

Company Website: